AXIOS July 13, 2023
The Food and Drug Administration on Thursday approved the first daily birth control pill to be sold without a prescription, in a move expected to reduce barriers to accessing contraceptives.
Why it matters: The cost of HRA Pharma’s Opill hasn’t been announced, leaving questions around affordability.
- Patrick Lockwood-Taylor, president and CEO of consumer products giant Perrigo, which owns HRA Pharma, said the FDA decision marks “a truly momentous day for women’s health nationwide.”
- The American College of Obstetricians and Gynecologists argues that since the Supreme Court overturned Roe v. Wade, increasing access to birth control through over-the-counter oral contraception is “critical” so that more people can “control their own reproductive futures, including avoiding pregnancy.”
Zoom out: With the...
Today's Sponsors
Today's Sponsor